Improved Beta-Cell Function GLP-1 medications may help preserve and improve the function of beta cells in the pancreas, which are responsible for producing insulin
M.HuangS.CurnutteJ.FowlerP.MartinezV.WehrC
Semaglutide and tirzepatide are medications in the class of glucagon-like peptides (GLP-1s), making them one option in the class of the most effective FDA approved treatments for weight loss
Considering the widespread expression of GLP-1 receptors in the brain, the authors recommend that future studies should focus on identifying the key neurocircuits involved in mediating the effects of GLP-1 receptor agonists on substance use disorder, as well as determine the specific patient subtypes who are most likely to benefit from these treatments
Gastroparesis and Semaglutide: FAQs Gastroparesis is a chronic condition characterized by delayed gastric emptying without a physical blockage
Foundayo offers a flexible oral GLP-1 option with no restrictions, and Zepbound introduces a dual-action approach for enhanced weight loss